- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/165 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
Patent holdings for IPC class A61K 31/165
Total number of patents in this class: 3602
10-year publication summary
239
|
277
|
273
|
289
|
318
|
303
|
280
|
230
|
226
|
91
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19784 |
46 |
Novartis AG | 10963 |
40 |
Newron Pharmaceuticals S.p.A. | 61 |
40 |
Les Laboratoires Servier | 539 |
36 |
LTS Lohmann Therapie-Systeme AG | 691 |
23 |
Murray and Poole Enterprises Limited | 25 |
21 |
Allergan, Inc. | 2362 |
20 |
The General Hospital Corporation | 4700 |
19 |
Axsome Malta Ltd. | 76 |
19 |
President and Fellows of Harvard College | 5935 |
17 |
Indiana University Research and Technology Corporation | 796 |
17 |
Vanda Pharmaceuticals, Inc. | 352 |
16 |
Board of Regents, The University of Texas System | 5738 |
15 |
Dana-Farber Cancer Institute, Inc. | 2545 |
15 |
Bristol-myers Squibb Company | 4896 |
14 |
BIAL - Portela & CA, S.A. | 224 |
14 |
Children's Medical Center Corporation | 1839 |
14 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2832 |
14 |
The Trustees of the University of Pennsylvania | 4295 |
13 |
The Johns Hopkins University | 5628 |
12 |
Other owners | 3177 |